Quick Search

  Wholesaler/Distributor Registration   l  My Cart   l   My Account  l  Home

 
Brands
  Pharmacist Nutriceuticals®
  USA Best®
  USA LABORATORIES®
  USA SPORTS LABS®
Products
  Health Concerns
  Sexual Health
  Specialty Supplements
  Vitamins & Minerals
  --------------------------------------------
  Weight Loss
  --------------------------------------------
  Children's
  --------------------------------------------
  Female
  Male
  --------------------------------------------
  Sports & Athletic Nutrition
  Extreme Hardcore Body Building
  Body Shaping
  Amino Acids
  Proteins
  Carbohydrates
  --------------------------------------------
  Food Bars
  --------------------------------------------
  Branded Ingredients
  --------------------------------------------
  Press Releases
  --------------------------------------------
  Employment
  Company Policy
CORAL CAL-1® (Coral Calcium-P%™) [click to enlarge]
USALCC60C - 3#

MSRP: $29.99
Internet Direct: $24.99

Bottles:


60 Capsules (CORAL CALCIUM-P%™)
AS SEEN ON TV!

100% PURE IONIZED BIOAVAILABLE CORAL CALCIUM w/PERFECT 2:1 CAL/MAG RATIO!

Pharmacist References:

Vitamin A References:
1. Rothman KJ, Moore LL, Singer MR, et al. Teratogenicity of high vitamin A intake. N Engl J Med 1995;333:1369-73.
2. Mastroiacovo P, Mazzone T, Addis A, et al. High vitamin A intake in early pregnancy and major malformations: a multicenter prospective controlled study. Teratology 1999;59:7-11.
3. Bendich A, Langseth L. Safety of vitamin A. Am J Clin Nutr 1989;49:358-71.
4. Mejiaa LA, Chew F. Hematological effect of supplementing anemic children with vitamin A alone and a combination with iron. Am J Clin Nutr 1988;48:595-600.

Vitamin C References:
1. Balz F. Antioxiant vitamins and heart disease. Presented at the 60th Annual Biology Colloquium, Oregon State University, Corvallis, Oregon, February 25, 1999.
2. Hemilä H. Does vitamin C alleviate the symptoms of the common cold? A review of current evidence Scand J Infect Dis
1994;26:1-6
3. Taddei S, Virdis A, Ghaidoni L, et al. Vitamin C improves endotheoium-dependent vasodilation by restoring nitric oxide activity in essential hypertension. Circulation 1998;97:2222-29
4. Chambers JC, McGregor A, Jean-Marie J, et al. Demonstration of rapid onset vascular endothelial dysfunction after hyperhomocysteinemia. An effect reversible with vitamin C therapy. Circulation 1999;99:1156-60.
5. Taylor A. Cataract: relationship between nutrition and sxidation. J Am Coll Nutr 1993;12:138-46 [review].
6. Taylor A, Jacques PF, Nadler D, et al. Relationship in humans between ascorbic acid consumption and levels of total and reduced ascorbic acid in lens, aqueous humor, and plasma. Curr Eye Res 1991;10:751-59.
7. Jacques PF, Chylack LT Jr. Epidemiologic evidence of a role for the antioxidant vitamins and carotenoids in cataract prevention. Am J Clin Nutr 1991;53:352S-55S
8. Jacques PF, Chylack LT, McGandy RB, Hartz SC. Antioxidant status in persons with and without senile cataract. Arch Ophthalmol 1988;106:337-40.
9. Robertson JM, Donner AP, Trevithick JR. vitamin E intake and risk of cataracts in humans Ann Nrl Acad Sci 1989;570:372-82.
10. Seddon JM, Christen WG, Manson JE, et al. The use of vitamin supplements and the risk of cataract among US male physicians. Am J Public Health 1994;84:788-792.
11. Vincent TE, mendiratta S, may JM. Inhibition of aldose reductase in human erythrocytes by vitamin C. diabetes Res Clin Pract1 999;43:1-8.
12. Simon JA. Ascorbic acid and cholesterol gallstones. Med Hypotheses 1993;40:81-84.
13. Levine M, Conry-Cantilena C, Wang Y, et al. Vitamin C pharmacokinetics in healthy volunteers evidence for a recommended dietary allowance. Proc Natl Acad Sci USA 1996;93:3704-709
14. Sandstead HH. Copper bioavailability and requirements. Am J clin Nutr 1982;35:809-14 [review].
15. Finley EB, Cerklewski FL. Influence of ascorbic acid supplementation on copper status in yound adult men. Am J Clin Nutr 1983;37:553-56.
16. Piesse JW. Nutritional factors in calcium containing kidney stones wiht particular emphasis on vitamin C. Int Clin Nutr Rev 1985;5(3):110-129 [review]
17. Ringsdorf WM, Cheraskin WM. Medical complications from ascorbic acid: review and interpretation (part one). J Holistic Med 1984;6(1):49-63.
18. Hoffer A. Ascorbic acid and kidney stones. Can Med Assoc J 1985;32:320 [letter]
19. Wandzilak TR, D'Andre SD, Davis PA, Williams HE. Effect of high dose vitamin C on urinary oxal levels. J Urol 1994;151:834-37.
20. Levine M. Vitamin C and optimal health. Presented at the February 25, 1999 60th Annual Biology Colloquium, Oregon State University, Corvallis, Oregon.
21. Levine M, Conry-Cantilena C, wang Y, et al. Vitamin C pharmacokinetics in healthy volunteers:evidnece for a recommended dietary allowance. proc Natl Acad Sci USA 1996;93:3704-709.
22. Auer BL, Auer D, Rodgers AL. Relative hyperoxaluria, crystalluria and haematuria after megadose ingestion of vitamin C. Eur J Clin Invest 1998;28:695-700.

Vitamin D References:
1. Hayes CE, Cantorna MT, Deiuca HF. Vitamin D and multiple sclerosis. Proc Soc Exper Biol Med 1997;216:21-27.
2. Labriji-Mestaghanmi H, Billaudel B, Garnier PE, Sutter BCJ. Vitamin D and pancreatic islet function 2. Time course for changes in insulin secretion and content during vitamin deprivation and repletion. Endocrine Invest 1988;11:577-87.
3. time course for changes in insulin seretion and content during vitamin deprivation and repletion Endocrine invest 1988,11.577-87.
4. Boucher BJ. Indequate vitamin D status: does it contribute to the disorders comprising syndrom 'X'? Br J Nutr 1998;79:315-27.
5. Chapuy M-C, Preziosi P, Maamer M, et al. Prevalence of vitamin D insufficency in an adult normal population. Osteoporosis Int 1997;7:439-43.
6. Thomas MK, Lloyd-Jones DM, Thadhani RI, et al. Hypovitaminosis D in medical inpatients. N Engl Meg 1998;338:777-83.
7. Dawson-Hughes B, Harris SS, Krall EA, et al. Rates of bone loss in postmenopausal women randomly assigned to one of twn dosages of vitmain D. Am J Clin Epidemio 1997,50:967-73.
8. Lind L, Sakrfors F, Rerglund L, et al. Serum calcium: A new independent prospective risk factor formula of myocardial infarction in middle-aged men followed for 18 years. J Clin Epidemio 1997,50:967-73.
9. Heikkinen A0M, Tuppurainen MT, Komulainen M, et al. Long-term vitamin D3 supplementation may have adverse effects on serum lipids during postmenopausal hormone replacement therapy. Eur J Endocrinol 1997;137:495-502.
10. Scragg R, Khaw K-T, Murphy S. Effect of winter oral vitamin D3 supplementation on cardiovascular risk factors in elderly adults. Eur J Clin Nutr 1995;49:640-46.

Vitamin E References:
1. Rimm EB, Stampfer MJ, Ascherio A, et al. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 1993; 328:1450-56.
2. Stampfer MJ, Hennekens CH, Manson JE, et al. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 1993; 328:1444-49.
3. Stephens NG, Parsons A, Schofield PM, et al. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 1996;347:781-86.
4. Christen S, Woodall AA, Shigenage MK, Southwell-Keely, Duncan MW, Ames BN. Gamma-tocopherol traps mutagenic electrophiles such as NO+ and complements alpha-tocopherol: physiological implications. Proc Natl Acad Sci 1997;94:3217-22.
5. Rimm E. Micronutrients, Coronary Heart disease and cancer: Should we all be on supplements? Presented at the 60th Annual Biology Colloquium, Oregon State University, February 25, 1999.

Iodine References:

Magnesium References:
1. Gaspar AZ, Gasser P, Flammer J. The influence of magnesium on visual field and peripheral vasospasm in glaucoma. Ophthalmologica 1995;209:11-13.
2. Kawano Y, Matsuoka H, Takishita S, Omae T. Effects of magnesium supplementation in hypertens patients. Hypertension 1998;32:260-65.
3. Starobrat-Hermelin B, Kozielec T. The effects of magnesium physiological supplementation on hyperactivity in children with attention deficit hyperactivity disorder (ADHD): Positive response to magnesium oral loading test. Magnesium Res 1997;10:149-56.
4. Cox IM, Campbell MJ, Dowson D. Red boood cell magnesium and chronic fatigue syndrome. Lanc 1991;337:757-60.
5. Howard JM, Davies S, Hunnisett A. Magnesium and chronic fatigue syndrome. Lancet 1992;340:426.
6. Gantz NM. Magnesium and chronic fatigue. Lancet 1991;338:66 [letter].
7. Hinds G, Bell NP, McMaster D, McCluskey DR. Normal red cell magnesium concentrations and magnesium loading tests in patients with chronic fatigue syndrome. Ann Clin Biochem 1994;31(Pt 5):459-61.
8. Weisinger JR, Bellorin-font, E. Magnesium and phosphorus. Lancet 1998;352:391-96 [review].

Zinc References:
1. Mossad SB, Macknin ML, Medendorp SV, et al. Zinc gluconate lozenges for treating the common cold. Ann Intern Med 1996;125:81 8.
2. Anonymous. Zinc lozenges reduce the duration of common cold symptoms. Nutr Rev1997;55:82 8 [review].
3. Garland ML, Hagmeyer KO. The role of zinc lozenges in treatment of the common cold. Ann Pharmacother 1998;32:93 69 [review].
4. Macknin ML, Piedmonte M, Calendine C, et al. Zinc gluconate lozenges for treating the common cold in children. A randomized controlled trial. JAMA 1998;279:1962 7.
5. Eby G. Where's the bias? Ann Intern Med 1998;128:75 [letter].
6. Garland ML, Hagmeyer KO. The role of zinc lozenges in treatment of the common cold. Ann Pharmacother 1998;32:63 9 [review].
7. Weismann K, Jakobsen JP, Weismann JE, et al. Zinc gluconate lozenges for common cold. A double blind clinical trial. Dan Med Bull 1990;37:279 81.
8. Bhutta ZA, Black RE, Brown KH, et al. Prevention of diarrhea and pneumonia by zinc supplementation in children in developing countries: pooled analysis of randomized

Selenium References:
1. Clark LC, Combs FG, Turnbull BW, et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. JAMA 1996;276:1957-63.
2. Yoshizawa K, Willett WC, Morris SJ, et al. Study of prediagnostic selenium levels in toenails and the risk of advanced prostate cancer. J Natl Cancer Inst 1998;20:15-20.
3. Yu S-Y, Li W-G, Zhu Y-J, et al. Chemoprevention trial of human hepatitis with selenium supplementation in China. Biol Trace Element Res 1989;20:15-20.
4. Peretz A, Neve J, Desmedt J, et al. Lymphocyte response is enhanced by supplementation of elderly subjects with selenium-enriched yeast. Am J Clin Nutri
1991;53:1323-28
5. Scott R, Macpherson A, Yates RWS, et al The effects of oral selenium supplementation on human sperm motility. Br J Urol 1998;82:76-80.
6. Dworkin BM. Selenium deficiency in HIV infection and the acquired immunodeficiency syndrome (AIDS). Chem Biol Iteract 1994;91:181-86.
7. Moore JA, Noiva R, Wells IC. Selenium concentractions in plasma of patients with arteriographically defined coronary atherosclerosis. Clin Chem 1984;30:1171-73.
8. Contempre B, Dumont JE, Ngo B, et al. Effects of selenium supplementation in hypothyroid subjects of an iodine and selenium deficient area: The possible danger of indiscriminate supplementation of iodine deficient subjects with selenium. J Clin Endocrinol Metabol 1991;73:213-15.

Copper References:
1. Sandstead HH. Requirements and toxicity of essential trace elements, illustrated by zinc and copper Am J Clin Nutr 1995;61(suppl):62S-64S.
2. Broun ER. Greist A, Tricot G, Hoffman R. Excessive zinc ingestion. A reversible cause of siderobla anemia and bone marrow depression. JAMA 1990;264:1441-43.
3. Jacob RA, Skala JH, Omaye ST, Turnlund JR. Effect of varying ascorbic acid intakes on copper absorption and ceruloplasmin levels of young men. J Nutr
1987;117:2109-15.

Manganese References:
1. Raloff J. Reasons for boning up on manganese. Science Sep 1986, 199 [review].
2. Krieger D, Kreiger S, Jansen O, et al. Manganese and chronic hepatic encephalopathy. Lancet 1995;346:270-74.
3. Freeland-Graves JH. Manganese: an essential nutrient for humans. Nutr Today 1989;23:13-19 [reveiw].

Chromium References:
1. Saner G, Yüzbasiyan V, Neyzi O, et al. Alterations of chromium metabolism and effect of chromium supplementation in Turner's syndrome patients. Am J Clin Nutr 1983;38:574-78.
2. Riales R, Albrink MJ. Effect of chromium chloride supplementation on glucose tolerance and serum lipids including high-density lipoprotein of adult men. Am J Clin Nutr 1981;34:2670-78.
3. Wang MM, Fox EZ, Stoecker BJ, et al. Serum cholesterol of adults supplemented with brewer's yeast or chromium chloride. Nutr Res 1989;9:989-98.
4. Page TG, Ward TL, and Southern LL. Effect of chromium picolinate on growth and carcass characteristics of growing-finishing pigs. J Animal Sci 1991;69:356.
5. Lefavi R, Anderson R, Keith R, et al. Efficacy of chromium supplementation in athletes: Emphasis on anabolism. Int J Sport Nutr 1992;2:111-22.
6. McCarty MF. The case for supplemental chromium and a survey of clinical studies with chromium picolinate. J Appl Nutr 1991;43:59-66.
7. Hallmark MA, Reynolds TH, DeSouza CA, et al. Effects of chromium and resistive training on muscle strength and body composition. Med Sci Spt Ex 1996;28:139-44.
8. Kaats GR, Blum K, Fisher JA, Adelman JA. Effects of chromium picolinate supplementation on body composition: a randomized, double-masked, placebo-controlled study. Curr Ther Res 1996;57:747-51.
9. Kaats GR, Blum K, Pullin D, Keither SC, Wood R. A randomized, double-masked, placebo-control study of the effects of chromium picolinate supplementation on body composition: a replication and extension of a previous study. Curr Ther Res 1998;59:379-88.
10. Sterns DM, Belbruno JJ, Wetterhahn KE. A prediction of chromium (III) accumulation in humans from chromium dietary supplements. FASEB J 1995;9:1650-57.
11. Sterns DM, Wise JP, Patierno SR, Wetterhahn KE. Chromium (III) picolinate produces chromosl damage in Chinese hamster ovary cells. FASEB J 1995;9:1643-49.
12. Garland M, Morris JS, Colditz GA, et al. Toenail trace element levels and breast cancer. AmJ Epidemiol 1996;144:653-60.
13. Cerulli J, Grabe DW, Guathier I, et al. Chromium picolinate toxicity. Ann Pharmacother
1998;32:428-31.
14. Wasser WG, Feldman NS. Chromic renal failure after ingestion of over-the-counter chromium picolinate. Ann Intern Med 1997;126:410 [letter].
15. Offenbacher EG. Promotion of chromium absorption by ascorbic acid. Trace Elements Electrolyte 1994;11:178-81.

Molybdenum References:
1. Johnson JL et al. Molybdenum cofactor deficiency in a patient previously characterized as deficient sulfite oxidase. Biochem Med Metabol Biol 1988;40:86-93.

Coral Calcium(General) References:
1. Osborne CG, McTyre RB, Dudek J, et al. Evidence for the relationship of calcium to blood pressure Nutr Rev 1996;54:365-81.
2. Barilla DE, Notz C, Kennedy D, Pak CYC. Renal oxalate excretion following oral oxalate loads in patrients with ileal disease and with renal and absorptive hypercalciurias: effect of calcium and magnesium. Am J Med 1978;64:579-85.
3. Curhan GC, Willett WC, Rimm EB, Stampfer MJ. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med 1993;328:833-83.
4. Bell L, Hastenson CE, Halstenson CJ, et al. Cholesterol-lowering effects of calcium carbonate in patients with mild to moderate hypercholesterolemia. Arch Intern Med 1992;152:2441-44.
5. Sheihk MS, Santa Ana CA, Nicar MJ, et al. Gastrointestinal absorption of calcium from milk and calcium salts. N Engl J Med 1987;317:532-36.
6. Levenson DI, Bockman RS. A review of calcium preparations. Nutr Rev 1994;52:221-32 [review].
7. Nicar MJ, Pak CYC. Calcium bioavailability from calcium carbonate and calcium citrate. J Clin Endocrinol Metabo 1985;61:391-93.
8. Harvey JA, Kenny P, Poindexter J, pak CYC. Superior calcium absorption from calcium citrate than calcium carbonate using external forearm counting. J Am Coll Nutr 1990;9:583-87.
9. Sheikh MS, Santa Ana CA, Nicar MJ, et at. Gastrointestinal absorption of calcium from milk and calcium salts. N Engl J Med 1987;317:532-36.
10. Epstein O, Kato Y, Dick R, Sherlock S. Vitamin D, hydroxyapatite, and calcium gluconate in treatment of cortical bone thinning in postmenopausal women with primary billiary cirrhosis. Am J Clin Nutr 1982;36:426-30.
11. Heaney RP, Recker RR, Weaver CM. Absorbability of calcium sources: the limited role of solubitt Calcif Tissue Int 1990;46:300-4.
12. Deroisy R, Zartarian M, Meurmans L, et al. Acute changes in serum calcium and parathyroid hormaone circulating levels induced by the oral intake of five currently available calcium salts in healthy male volunteers. Clin Rheumatol 1997;16:249-53.
13. Burros M. Testing calcium supplements for lead. New York Times June 4, 1997,B7.
14. Bourgoin BP, Evans DR, Cornett JR, et al. Lead content in 70 brands of dietary calcium supplements. Am J Publ Health 1993;83:1155-60.
15. Civitelli R, Villareal DT, Agnusdei D, et al. Dietary L-lysine and calcium metabolism in humans. Nutrition 1992;8:400-5.
16. Flodin NW. The metabolic roles; pharmacology, and toxicology of lysine. J Am Coll Nutr 1997;16:7-21 [rview].

Vanadyl References:

Boron References:


  • Back To List
  • Wholesaler/Distributor Registration   l  My Cart   l   My Account  l  Home  l  Return to Top of Page

        Nasvhille Chamber of Commerce Dickson County Chamber of Commerce U.S. Commercial Service

    *These statements have not been evaluated by the F.D.A. *USA Laboratories makes no representation or warranties concerning the use of our products for the diagnosis, cure, mitigation, treatment or prevention of any disease. *Seek advice from a health care provider before using this or any supplement product.

    Powered By LionZone Copyright © USA LABORATORIES, INC. All rights reserved.